A micelle-based stage-by-stage impelled system for efficient doxorubicin delivery
Open Access
- 1 July 2023
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 25, 783-795
Abstract
Chemotherapy remains the mainstay of cancer treatment, benefiting millions of patients each year, but the side effects of chemotherapy drugs severely limit their clinical use. Doxorubicin (DOX) can cause various side effects such as heart damage and treatment-related tumors. The effective use of active and passive targeting will improve the clinical application of DOX. Here, TPGS3350 and bioactive peptides were utilized to construct a micelle-based stage-by-stage impelled efficient system (missiles) for DOX delivery (DOX missiles). By taking advantage of the EPR effect, DOX missiles are efficiently enriched at the tumor site. After being cleaved by matrix metalloproteinase2 (MMP2), the peptide (VRGD) targets tumor cells to facilitate uptake of the missiles by the tumor cells via receptor-mediated endocytosis. The intracellular activated caspase-3-catalyzed explosion of DOX missiles further enables efficient tumor killing. This study provides an efficient approach for DOX delivery and toxicity reduction.Keywords
Funding Information
- National Natural Science Foundation of China (19JCZDJC64100, 22078246, 22178270, 32030060, 51861135103, 82102204)
- Ministry of Science and Technology of the People's Republic of China
- China Postdoctoral Science Foundation (2020M680478)
- National Key Research and Development Program of China (2018YFE0117800, 2021YFA1201000)
- Central Military Commission (2.83 × 10−3 mg/mL, 4.44 × 10−3 mg/mL)
This publication has 50 references indexed in Scilit:
- Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistanceBiomaterials, 2016
- Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistanceProceedings of the National Academy of Sciences, 2015
- Prevention of Anthracycline-Induced CardiotoxicityJACC, 2014
- Doxil® — The first FDA-approved nano-drug: Lessons learnedJournal of Controlled Release, 2012
- Doxorubicin-induced ovarian toxicityReproductive Biology and Endocrinology, 2010
- Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomasEuropean Journal of Pediatrics, 2008
- Anthracycline cardiotoxicityThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2006
- Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patientsBlood, 2003
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002